Scorpion venoms in gastric cancer (Review) Retraction in /10.3892/ol.2020.12063

Zhang,Xiao-Ying; Zhang,Pei-Ying

doi:10.3892/ol.2016.5134

Scorpion venoms in gastric cancer (Review)

Retraction in: /10.3892/ol.2020.12063

Authors:
- Xiao-Ying Zhang
- Pei-Ying Zhang
View Affiliations

Affiliations: Nanjing University of Chinese Medicine, Information Institute, Nanjing, Jiangsu 221009, P.R. China, Department of Cardiology, Xuzhou Central Hospital, The Affiliated Xuzhou Hospital of Medical College of Southeast University, Xuzhou, Jiangsu 221009, P.R. China
Published online on: September 14, 2016 https://doi.org/10.3892/ol.2016.5134
Pages: 3683-3686
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Venom secretions from snakes, scorpions, spiders and bees, have been widely applied in traditional medicine and current biopharmaceutical research. Possession of anticancer potential is another novel discovery for animal venoms and toxins. An increasing number of studies have shown the anticancer effects of venoms and toxins of snakes, and scorpions in vitro and in vivo, which were achieved mainly through the inhibition of cancer growth, arrest of cell cycle, induction of apoptosis and suppression of cancer metastasis. However, more evidence is needed to support this concept and the mechanisms of anticancer actions are not clearly understood. The present review is focused on the recant updates on anticancer venom research.

View Figures

View References

1	Zhang L, Chen C, Cao Y, Xie B, Chen X, Zeng F and Liu M: Purification and immunoprotection evaluation of AaHIV from complex venom metalloproteinases of Deinagkistrodon acutus. J Biochem Mol Toxicol. Apr 25–2016.(Epub ahead of print). View Article : Google Scholar
2	Weinstein S, Dart R, Staples A and White J: Envenomations: an overview of clinical toxinology for the primary care physician. Am Fam Physician. 80:793–802. 2009.PubMed/NCBI
3	Meng Z, Yang P, Shen Y, Bei W, Zhang Y, Ge Y, Newman RA, Cohen L, Liu L, Thornton B, et al: Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer. Cancer. 115:5309–5318. 2009. View Article : Google Scholar : PubMed/NCBI
4	Lewis RJ and Garcia ML: Therapeutic potential of venom peptides. Nat Rev Drug Discov. 2:790–802. 2003. View Article : Google Scholar : PubMed/NCBI
5	Andreotti N, Jouirou B, Mouhat S, Mouhat L and Sabatier JM: Therapeutic value of peptides from animal venomsComprehensive Natural Products II. Mander L and Liu HW: 5. Elsevier; Oxford: pp. 287–303. 2010, View Article : Google Scholar
6	Srinivasan KN, Gopalakrishnakone P, Tan PT, Chew KC, Cheng B, Kini RM, Koh JL, Seah SH and Brusic V: SCORPION, a molecular database of scorpion toxins. Toxicon. 40:23–31. 2002. View Article : Google Scholar : PubMed/NCBI
7	Quintero-Hernández V, Jiménez-Vargas JM, Gurrola GB, Valdivia HH and Possani LD: Scorpion venom components that affect ion-channels function. Toxicon. 76:328–342. 2013. View Article : Google Scholar : PubMed/NCBI
8	Rodríguez de la Vega RC and Possani LD: Current views on scorpion toxins specific for K⁺-channels. Toxicon. 43:865–875. 2004. View Article : Google Scholar : PubMed/NCBI
9	Diego-García E, Peigneur S, Debaveye S, Gheldof E, Tytgat J and Caliskan F: Novel potassium channel blocker venom peptides from Mesobuthus gibbosus (Scorpiones: Buthidae). Toxicon. 61:72–82. 2013. View Article : Google Scholar : PubMed/NCBI
10	Castle NA: Pharmacological modulation of voltage-gated potassium channels as a therapeutic strategy. Expert Opin Ther Pat. 20:1471–1503. 2010. View Article : Google Scholar : PubMed/NCBI
11	Asher V, Sowter H, Shaw R, Bali A and Khan R: Eag and HERG potassium channels as novel therapeutic targets in cancer. World J Surg Oncol. 8:1132010. View Article : Google Scholar : PubMed/NCBI
12	Possani LD, Merino E, Corona M, Bolivar F and Becerril B: Peptides and genes coding for scorpion toxins that affect ion-channels. Biochimie. 82:861–868. 2000. View Article : Google Scholar : PubMed/NCBI
13	DeBin JA, Maggio JE and Strichartz GR: Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion. Am J Physiol. 264:C361–C369. 1993.PubMed/NCBI
14	Lyons SA, O'Neal J and Sontheimer H: Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin. Glia. 39:162–173. 2002. View Article : Google Scholar : PubMed/NCBI
15	Mamelak AN, Rosenfeld S, Bucholz R, Raubitschek A, Nabors LB, Fiveash JB, Shen S, Khazaeli MB, Colcher D, Liu A, et al: Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma. J Clin Oncol. 24:3644–3650. 2006. View Article : Google Scholar : PubMed/NCBI
16	Almaaytah A and Albalas Q: Scorpion venom peptides with no disulfide bridges: a review. Peptides. 51:35–45. 2014. View Article : Google Scholar : PubMed/NCBI
17	Hancock RE and Sahl HG: Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol. 24:1551–1557. 2006. View Article : Google Scholar : PubMed/NCBI
18	Torres-Larios A, Gurrola GB, Zamudio FZ and Possani LD: Hadrurin, a new antimicrobial peptide from the venom of the scorpion Hadrurus aztecus. Eur J Biochem. 267:5023–5025. 2000. View Article : Google Scholar : PubMed/NCBI
19	Dai C, Ma Y, Zhao Z, Zhao R, Wang Q, Wu Y, Cao Z and Li W: Mucroporin, the first cationic host defense peptide from the venom of Lychas mucronatus. Antimicrob Agents Chemother. 52:3967–3972. 2008. View Article : Google Scholar : PubMed/NCBI
20	Gwee MC, Nirthanan S, Khoo HE, Gopalakrishnakone P, Kini RM and Cheah LS: Autonomic effects of some scorpion venoms and toxins. Clin Exp Pharmacol Physiol. 29:795–801. 2002. View Article : Google Scholar : PubMed/NCBI
21	Petricevich VL: Scorpion venom and the inflammatory response. Mediators Inflamm. 2010:9032952010. View Article : Google Scholar : PubMed/NCBI
22	Girish KS and Kemparaju K: The magic glue hyaluronan and its eraser hyaluronidase: a biological overview. Life Sci. 80:1921–1943. 2007. View Article : Google Scholar : PubMed/NCBI
23	Feng L, Gao R and Gopalakrishnakone P: Isolation and characterization of a hyaluronidase from the venom of Chinese red scorpion Buthus martensi. Comp Biochem Physiol C Toxicol Pharmacol. 148:250–257. 2008. View Article : Google Scholar : PubMed/NCBI
24	Burke JE and Dennis EA: Phospholipase A₂ structure/function, mechanism, and signaling. J Lipid Res. 50:S237–S242. 2009. View Article : Google Scholar : PubMed/NCBI
25	Incamnoi P, Patramanon R, Thammasirirak S, Chaveerach A, Uawonggul N, Sukprasert S, Rungsa P, Daduang J and Daduang S: Heteromtoxin (HmTx), a novel heterodimeric phospholipase A(2) from Heterometrus laoticus scorpion venom. Toxicon. 61:62–71. 2013. View Article : Google Scholar : PubMed/NCBI
26	Samy R Perumal, Gopalakrishnakone P, Thwin MM, Chow TK, Bow H, Yap EH and Thong TW: Antibacterial activity of snake, scorpion and bee venoms: a comparison with purified venom phospholipase A₂ enzymes. J Appl Microbiol. 102:650–659. 2007. View Article : Google Scholar : PubMed/NCBI
27	Valdez-Velázquez LL, Quintero-Hernández V, Romero- Gutiérrez MT, Coronas FIV and Possani LD: Mass fingerprinting of the venom and transcriptome of venom gland of scorpion Centruroides tecomanus. PLoS One. 8:e664862013. View Article : Google Scholar : PubMed/NCBI
28	Fletcher PL Jr, Fletcher MD, Weninger K, Anderson TE and Martin BM: Vesicle-associated membrane protein (VAMP) cleavage by a new metalloprotease from the Brazilian scorpion Tityus serrulatus. J Biol Chem. 285:7405–7416. 2010. View Article : Google Scholar : PubMed/NCBI
29	Gao F, Li H, Chen YD, Yu XN, Wang R and Chen XL: Upregulation of PTEN involved in scorpion venom-induced apoptosis in a lymphoma cell line. Leuk Lymphoma. 50:633–641. 2009. View Article : Google Scholar : PubMed/NCBI
30	Du XY and Clemetson KJ: Snake venom L-amino acid oxidases. Toxicon. 40:659–665. 2002. View Article : Google Scholar : PubMed/NCBI
31	Ahn MY, Ryu KS, Lee YW and Kim YS: Cytotoxicity and L-amino acid oxidase activity of crude insect drugs. Arch Pharm Res. 23:477–481. 2000. View Article : Google Scholar : PubMed/NCBI
32	Tan NH and Fung SY: Snake venom L-amino acid oxidases and their potential biomedical applications. Malaysian J Biochem Mole Biol. 16:1–10. 2008.
33	Shao J, Kang N, Liu Y, Song S, Wu C and Zhang J: Purification and characterization of an analgesic peptide from Buthus martensii Karsch. Biomed Chromatogr. 21:1266–1271. 2007. View Article : Google Scholar : PubMed/NCBI
34	Chen Y, Cao L, Zhong M, Zhang Y, Han C, Li Q, Yang J, Zhou D, Shi W, He B, et al: Anti-HIV-1 activity of a new scorpion venom peptide derivative Kn2-7. PLoS One. 7:e349472012. View Article : Google Scholar : PubMed/NCBI
35	Ding J, Chua PJ, Bay BH and Gopalakrishnakone P: Scorpion venoms as a potential source of novel cancer therapeutic compounds. Exp Biol Med (Maywood). 239:387–393. 2014. View Article : Google Scholar : PubMed/NCBI
36	Zhang J, Yang PL and Gray NS: Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer. 9:28–39. 2009. View Article : Google Scholar : PubMed/NCBI
37	Zhao Y, Cai X, Ye T, Huo J, Liu C, Zhang S and Cao P: Analgesic-antitumor peptide inhibits proliferation and migration of SHG-44 human malignant glioma cells. J Cell Biochem. 112:2424–2434. 2011. View Article : Google Scholar : PubMed/NCBI
38	Deshane J, Garner CC and Sontheimer H: Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J Biol Chem. 278:4135–4144. 2003. View Article : Google Scholar : PubMed/NCBI